CIALIS (STAT RX USA LLC)
Welcome to the PulseAid listing for the CIALIS drug offered from STAT RX USA LLC. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | STAT RX USA LLC |
NON-PROPRIETARY NAME: | TADALAFIL |
SUBSTANCE NAME: | TADALAFIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-11-26 |
END MARKETING DATE: | 0000-00-00 |
CIALIS HUMAN PRESCRIPTION DRUG Details:
Item Description | CIALIS from STAT RX USA LLC |
LABELER NAME: | STAT RX USA LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2003-11-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16590-905_13afc5a5-a6d6-42bc-a8f3-24da926747c7 |
PRODUCT NDC: | 16590-905 |
APPLICATION NUMBER: | NDA021368 |
Other TADALAFIL Pharmaceutical Manufacturers / Labelers: